Description:

CALGB 40601 TREATMENT FORM Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery NCT00770809 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=3A0519D7-D7F7-3073-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=3A0519D7-D7F7-3073-E044-0003BA3F9857

Keywords:
Versions (2) ▾
  1. 8/26/12
  2. 1/8/15
Uploaded on:

January 8, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

TREATMENT FORM Breast Cancer (NCT00770809)

INSTRUCTIONS: Complete and submit this form as required by the protocol. Information in the upper right box must be completed for this form to be accepted. For optimal accuracy use black ink. Mark an X in the appropriate box for fields with a choice.

Header
Are data amended
Bevacizumab/placebo
Assigned Treatment Arm
On Treatment Report Period
Bevacizumab/placebo
Were there any delays in dose administration
Was treatment discontinued during this period?
Bevacizumab/placebo
Were there any delays in dose administration
Was treatment discontinued during this period?
Bevacizumab/placebo
Were there any delays in dose administration
Was treatment discontinued during this period?
Muga Results
Time point (Mark one with an X.)
%
%
Has the patient experienced a drop of at least 15 percentage points in the current LVEF compared with the baseline value

Similar models